市場調査レポート

商品コード

1494837

感染症診断の世界市場：分析 - 製品別、疾患別、技術別、エンドユーザー別、地域別、予測（～2030年）

Infectious Disease Diagnostics Market Forecasts to 2030 - Global Analysis By Product, Disease, Technology, End User and By Geography

出版日: 2024年06月06日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,150 617,935円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回のみ可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (2-5 User License)

USD 5,250 781,725円

レポートPDFを同一事業所（所在地）内の5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF & Excel (Site License)

USD 6,350 945,515円

レポートPDFおよびExcelを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は5回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Global Site License)

USD 7,500 1,116,750円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は10回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=148.90円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の感染症診断の市場規模は、2024年に236億3,000万米ドルに達し、予測期間中にCAGR 10.4%で成長し、2030年には427億8,000万米ドルに達すると予測されています。

感染症診断とは、感染症を診断するために、人の体内の細菌、ウイルス、真菌、寄生虫などの病原体の存在を特定するプロセスを指します。これらの診断には、特定の病原体やそのマーカーを検出することを目的とした様々な技術や方法が用いられ、多くの場合、体液や組織、その他のサンプルを分析することによって行われます。また、迅速診断検査（RDT）は、資源が限られている環境での迅速な同定にも利用されています。感染症を正確かつタイムリーに診断することは、効果的な患者管理、適切な治療の開始、感染対策の実施、疾病サーベイランスのために極めて重要です。

米国疾病予防管理センター（CDC）によると、2018年、米国の病院では毎年約170万件の感染症と9万9,000件の関連死が発生していると報告されています。米国食品医薬品局（FDA）によると、2020年には、50歳以上の約30万人が毎年肺炎球菌性肺炎と診断されると報告されています。

ポイントオブケア検査への需要の高まり

ポイントオブケア検査は、迅速で便利な分散型検査ソリューションを提供し、患者のベッドサイドや地域環境で迅速な診断とタイムリーな治療決定を可能にします。このようなPOCTへのシフトは、特にCOVID-19のような感染症の大流行やパンデミックにおいて、迅速なターンアラウンドタイムが必要とされるなど、いくつかの要因によって推進されています。さらに、POCTは中央集中型の検査施設やヘルスケアインフラへの負担を軽減し、十分なサービスを受けていない人々や遠隔地でも検査を受けやすくします。

高い診断検査費用

診断検査費用の高さは、感染症診断市場の成長にとって大きな障壁となっています。これらの費用には、検査開発、製造、流通などさまざまな側面が含まれ、これらすべてが患者やヘルスケアシステムが負担する最終的な価格に寄与しています。特に中低所得国の多くの患者にとって、これらの費用は法外であり、診断の遅れや見逃し、その後の治療につながります。しかし、高額な費用はヘルスケア予算を圧迫し、必要不可欠な診断サービスへのアクセスを制限します。

公衆衛生意識の高まり

公衆衛生意識の高まりは、感染症診断市場の成長に大きく寄与しています。感染症の早期発見と予防の重要性に対する理解が高まるにつれ、個人も政府も診断技術により多くの資源を投資するようになっています。COVID-19パンデミックのような世界の健康危機は、アウトブレイクを封じ込め、公衆衛生対応を導く上で診断検査が果たす重要な役割を浮き彫りにしました。その結果、迅速で正確、かつコスト効率の高い診断ソリューションの開発と導入が重視されるようになり、感染症診断市場のイノベーションが促進され、医療従事者、研究開発機関、診断薬企業間の協力が促進されています。

診断手順の複雑さ

診断手順の複雑さは、感染症診断市場の成長に大きな障害となっています。こうした複雑さには、検査手法に関わる技術的な複雑さ、結果を得るまでの所要時間の長さ、検査を正確に実施・解釈するための熟練者の必要性など、さまざまな側面が含まれます。しかし、感染因子の多様性とその進化する性質は、診断プロトコルをさらに複雑にし、検出技術の継続的な更新と適応を必要とします。このような複雑さは、ヘルスケアシステムのコスト負担を増加させるだけでなく、感染症のタイムリーで効果的な診断と治療の妨げにもなっています。

COVID-19の影響：

COVID-19パンデミックは感染症診断市場に大きな影響を与えました。ウイルスを検出するための診断検査に対する需要がかつてないほど急増し、市場の急速な拡大につながった。パンデミックは、感染症の制圧における診断検査の重要性を浮き彫りにし、新規診断技術の研究開発投資の増加につながった。しかし、パンデミックはサプライチェーンや流通網を混乱させ、検査キットや試薬の一時的な不足を引き起こしました。

予測期間中、真菌感染症分野が最大となる見込み

真菌感染症分野は、特に免疫不全者の間で侵襲性真菌症が流行していることから、予測期間中、感染症診断市場において最大規模になると予測されています。認知度の向上、診断技術の進歩、真菌病原体をタイムリーかつ正確に特定する必要性が市場成長の原動力となっています。院内感染の発生率の増加、真菌感染に関連する高い罹患率と死亡率は、さらにこのセグメントの拡大に寄与しています。

次世代シーケンシング分野は予測期間中に最も高いCAGRが見込まれる

次世代シーケンシング分野は、病原体の遺伝物質を迅速かつ包括的に解析できることから、予測期間中に最も高いCAGRが見込まれます。この技術により、1回の検査で細菌、ウイルス、真菌、寄生虫を含む複数の感染因子を同時に検出し、その特徴を明らかにすることができます。病原体の全ゲノムまたは特定領域の配列を決定することにより、NGSはその遺伝的多様性、薬剤耐性プロファイル、疫学的パターンに関する貴重な洞察を提供することができます。この包括的なアプローチにより、感染症診断の精度と効率が向上し、特に従来の方法では原因菌の同定や近縁株の区別ができない場合があります。さらに、NGSは新興感染症の検出とアウトブレイクのリアルタイムでのモニタリングを容易にし、ヘルスケア専門家がより良い疾病管理と制御のためにタイムリーで的を絞った介入を実施できるようにします。

最大のシェアを占める地域

推定期間を通じて、アジア太平洋が市場で最大のシェアを占めています。人口の高齢化に伴い、免疫力の低下やその他の加齢関連要因により、感染症にかかりやすくなるのは自然なことです。このような人口動態の変化により、高齢者の感染症を効果的に検出・管理するための診断ツールやサービスに対する需要が高まっています。さらに、都市化、ライフスタイルの変化、ヘルスケア施設へのアクセス向上などの要因も、同地域における感染症診断市場の拡大に寄与しています。

CAGRが最も高い地域：

欧州地域は予測期間中、収益性の高い成長を維持する見込みです。欧州連合（EU）の体外診断用医薬品規制（IVDR）のような厳格な規制枠組みを通じて、当局は診断検査の品質、安全性、有効性を保証しています。これらの規制は製品開発と製造に高い基準を設けるだけでなく、革新的な診断技術のタイムリーな承認と市場参入を促進します。さらに、これらの規制を遵守することにより、医療従事者や患者の信頼が醸成され、その結果、先進的な診断ソリューションの地域的な導入が促進されます。

北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- 英国
- イタリア
- フランス
- スペイン
- その他の欧州
アジア太平洋
- 日本
- 中国
- インド
- オーストラリア
- ニュージーランド
- 韓国
- その他のアジア太平洋
南米
- アルゼンチン
- ブラジル
- チリ
- その他の南米
中東・アフリカ
- サウジアラビア
- アラブ首長国連邦
- カタール
- 南アフリカ
- その他の中東・アフリカ

第10章主な発展

契約、パートナーシップ、コラボレーション、合弁事業
買収と合併
新製品発売
事業拡大
その他の主要戦略

第11章企業プロファイリング

Bio-Rad Laboratories, Inc
Hologic, Inc
Luminex Corporation
Abbott Laboratories
GenMark Diagnostics, Inc
PerkinElmer, Inc
Thermo Fisher Scientific Inc
Bruker Corporation
Sysmex Corporation
Nanosphere Health Sciences Inc
Trinity Biotech plc
InBios International, Inc
Meridian Bioscience, Inc

図表

List of Tables

Table 1 Global Infectious Disease Diagnostics Market Outlook, By Region (2022-2030) ($MN)
Table 2 Global Infectious Disease Diagnostics Market Outlook, By Product (2022-2030) ($MN)
Table 3 Global Infectious Disease Diagnostics Market Outlook, By Assays & Reagents (2022-2030) ($MN)
Table 4 Global Infectious Disease Diagnostics Market Outlook, By Kits (2022-2030) ($MN)
Table 5 Global Infectious Disease Diagnostics Market Outlook, By Consumables (2022-2030) ($MN)
Table 6 Global Infectious Disease Diagnostics Market Outlook, By Instruments (2022-2030) ($MN)
Table 7 Global Infectious Disease Diagnostics Market Outlook, By Software & Services (2022-2030) ($MN)
Table 8 Global Infectious Disease Diagnostics Market Outlook, By Disease (2022-2030) ($MN)
Table 9 Global Infectious Disease Diagnostics Market Outlook, By Bacterial Infections (2022-2030) ($MN)
Table 10 Global Infectious Disease Diagnostics Market Outlook, By Viral Infections (2022-2030) ($MN)
Table 11 Global Infectious Disease Diagnostics Market Outlook, By Fungal Infections (2022-2030) ($MN)
Table 12 Global Infectious Disease Diagnostics Market Outlook, By Parasitic Infections (2022-2030) ($MN)
Table 13 Global Infectious Disease Diagnostics Market Outlook, By Other Infectious Diseases (2022-2030) ($MN)
Table 14 Global Infectious Disease Diagnostics Market Outlook, By Technology (2022-2030) ($MN)
Table 15 Global Infectious Disease Diagnostics Market Outlook, By Immunodiagnostics (2022-2030) ($MN)
Table 16 Global Infectious Disease Diagnostics Market Outlook, By Microbiology (2022-2030) ($MN)
Table 17 Global Infectious Disease Diagnostics Market Outlook, By Polymerase Chain Reaction (2022-2030) ($MN)
Table 18 Global Infectious Disease Diagnostics Market Outlook, By Next-generation Sequencing (2022-2030) ($MN)
Table 19 Global Infectious Disease Diagnostics Market Outlook, By Other Technologies (2022-2030) ($MN)
Table 20 Global Infectious Disease Diagnostics Market Outlook, By End User (2022-2030) ($MN)
Table 21 Global Infectious Disease Diagnostics Market Outlook, By Diagnostic Laboratories (2022-2030) ($MN)
Table 22 Global Infectious Disease Diagnostics Market Outlook, By Academic Research Institutes (2022-2030) ($MN)
Table 23 Global Infectious Disease Diagnostics Market Outlook, By Hospitals (2022-2030) ($MN)
Table 24 Global Infectious Disease Diagnostics Market Outlook, By Other End Users (2022-2030) ($MN)
Table 25 North America Infectious Disease Diagnostics Market Outlook, By Country (2022-2030) ($MN)
Table 26 North America Infectious Disease Diagnostics Market Outlook, By Product (2022-2030) ($MN)
Table 27 North America Infectious Disease Diagnostics Market Outlook, By Assays & Reagents (2022-2030) ($MN)
Table 28 North America Infectious Disease Diagnostics Market Outlook, By Kits (2022-2030) ($MN)
Table 29 North America Infectious Disease Diagnostics Market Outlook, By Consumables (2022-2030) ($MN)
Table 30 North America Infectious Disease Diagnostics Market Outlook, By Instruments (2022-2030) ($MN)
Table 31 North America Infectious Disease Diagnostics Market Outlook, By Software & Services (2022-2030) ($MN)
Table 32 North America Infectious Disease Diagnostics Market Outlook, By Disease (2022-2030) ($MN)
Table 33 North America Infectious Disease Diagnostics Market Outlook, By Bacterial Infections (2022-2030) ($MN)
Table 34 North America Infectious Disease Diagnostics Market Outlook, By Viral Infections (2022-2030) ($MN)
Table 35 North America Infectious Disease Diagnostics Market Outlook, By Fungal Infections (2022-2030) ($MN)
Table 36 North America Infectious Disease Diagnostics Market Outlook, By Parasitic Infections (2022-2030) ($MN)
Table 37 North America Infectious Disease Diagnostics Market Outlook, By Other Infectious Diseases (2022-2030) ($MN)
Table 38 North America Infectious Disease Diagnostics Market Outlook, By Technology (2022-2030) ($MN)
Table 39 North America Infectious Disease Diagnostics Market Outlook, By Immunodiagnostics (2022-2030) ($MN)
Table 40 North America Infectious Disease Diagnostics Market Outlook, By Microbiology (2022-2030) ($MN)
Table 41 North America Infectious Disease Diagnostics Market Outlook, By Polymerase Chain Reaction (2022-2030) ($MN)
Table 42 North America Infectious Disease Diagnostics Market Outlook, By Next-generation Sequencing (2022-2030) ($MN)
Table 43 North America Infectious Disease Diagnostics Market Outlook, By Other Technologies (2022-2030) ($MN)
Table 44 North America Infectious Disease Diagnostics Market Outlook, By End User (2022-2030) ($MN)
Table 45 North America Infectious Disease Diagnostics Market Outlook, By Diagnostic Laboratories (2022-2030) ($MN)
Table 46 North America Infectious Disease Diagnostics Market Outlook, By Academic Research Institutes (2022-2030) ($MN)
Table 47 North America Infectious Disease Diagnostics Market Outlook, By Hospitals (2022-2030) ($MN)
Table 48 North America Infectious Disease Diagnostics Market Outlook, By Other End Users (2022-2030) ($MN)
Table 49 Europe Infectious Disease Diagnostics Market Outlook, By Country (2022-2030) ($MN)
Table 50 Europe Infectious Disease Diagnostics Market Outlook, By Product (2022-2030) ($MN)
Table 51 Europe Infectious Disease Diagnostics Market Outlook, By Assays & Reagents (2022-2030) ($MN)
Table 52 Europe Infectious Disease Diagnostics Market Outlook, By Kits (2022-2030) ($MN)
Table 53 Europe Infectious Disease Diagnostics Market Outlook, By Consumables (2022-2030) ($MN)
Table 54 Europe Infectious Disease Diagnostics Market Outlook, By Instruments (2022-2030) ($MN)
Table 55 Europe Infectious Disease Diagnostics Market Outlook, By Software & Services (2022-2030) ($MN)
Table 56 Europe Infectious Disease Diagnostics Market Outlook, By Disease (2022-2030) ($MN)
Table 57 Europe Infectious Disease Diagnostics Market Outlook, By Bacterial Infections (2022-2030) ($MN)
Table 58 Europe Infectious Disease Diagnostics Market Outlook, By Viral Infections (2022-2030) ($MN)
Table 59 Europe Infectious Disease Diagnostics Market Outlook, By Fungal Infections (2022-2030) ($MN)
Table 60 Europe Infectious Disease Diagnostics Market Outlook, By Parasitic Infections (2022-2030) ($MN)
Table 61 Europe Infectious Disease Diagnostics Market Outlook, By Other Infectious Diseases (2022-2030) ($MN)
Table 62 Europe Infectious Disease Diagnostics Market Outlook, By Technology (2022-2030) ($MN)
Table 63 Europe Infectious Disease Diagnostics Market Outlook, By Immunodiagnostics (2022-2030) ($MN)
Table 64 Europe Infectious Disease Diagnostics Market Outlook, By Microbiology (2022-2030) ($MN)
Table 65 Europe Infectious Disease Diagnostics Market Outlook, By Polymerase Chain Reaction (2022-2030) ($MN)
Table 66 Europe Infectious Disease Diagnostics Market Outlook, By Next-generation Sequencing (2022-2030) ($MN)
Table 67 Europe Infectious Disease Diagnostics Market Outlook, By Other Technologies (2022-2030) ($MN)
Table 68 Europe Infectious Disease Diagnostics Market Outlook, By End User (2022-2030) ($MN)
Table 69 Europe Infectious Disease Diagnostics Market Outlook, By Diagnostic Laboratories (2022-2030) ($MN)
Table 70 Europe Infectious Disease Diagnostics Market Outlook, By Academic Research Institutes (2022-2030) ($MN)
Table 71 Europe Infectious Disease Diagnostics Market Outlook, By Hospitals (2022-2030) ($MN)
Table 72 Europe Infectious Disease Diagnostics Market Outlook, By Other End Users (2022-2030) ($MN)
Table 73 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Country (2022-2030) ($MN)
Table 74 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Product (2022-2030) ($MN)
Table 75 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Assays & Reagents (2022-2030) ($MN)
Table 76 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Kits (2022-2030) ($MN)
Table 77 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Consumables (2022-2030) ($MN)
Table 78 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Instruments (2022-2030) ($MN)
Table 79 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Software & Services (2022-2030) ($MN)
Table 80 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Disease (2022-2030) ($MN)
Table 81 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Bacterial Infections (2022-2030) ($MN)
Table 82 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Viral Infections (2022-2030) ($MN)
Table 83 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Fungal Infections (2022-2030) ($MN)
Table 84 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Parasitic Infections (2022-2030) ($MN)
Table 85 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Other Infectious Diseases (2022-2030) ($MN)
Table 86 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Technology (2022-2030) ($MN)
Table 87 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Immunodiagnostics (2022-2030) ($MN)
Table 88 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Microbiology (2022-2030) ($MN)
Table 89 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Polymerase Chain Reaction (2022-2030) ($MN)
Table 90 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Next-generation Sequencing (2022-2030) ($MN)
Table 91 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Other Technologies (2022-2030) ($MN)
Table 92 Asia Pacific Infectious Disease Diagnostics Market Outlook, By End User (2022-2030) ($MN)
Table 93 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Diagnostic Laboratories (2022-2030) ($MN)
Table 94 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Academic Research Institutes (2022-2030) ($MN)
Table 95 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Hospitals (2022-2030) ($MN)
Table 96 Asia Pacific Infectious Disease Diagnostics Market Outlook, By Other End Users (2022-2030) ($MN)
Table 97 South America Infectious Disease Diagnostics Market Outlook, By Country (2022-2030) ($MN)
Table 98 South America Infectious Disease Diagnostics Market Outlook, By Product (2022-2030) ($MN)
Table 99 South America Infectious Disease Diagnostics Market Outlook, By Assays & Reagents (2022-2030) ($MN)
Table 100 South America Infectious Disease Diagnostics Market Outlook, By Kits (2022-2030) ($MN)
Table 101 South America Infectious Disease Diagnostics Market Outlook, By Consumables (2022-2030) ($MN)
Table 102 South America Infectious Disease Diagnostics Market Outlook, By Instruments (2022-2030) ($MN)
Table 103 South America Infectious Disease Diagnostics Market Outlook, By Software & Services (2022-2030) ($MN)
Table 104 South America Infectious Disease Diagnostics Market Outlook, By Disease (2022-2030) ($MN)
Table 105 South America Infectious Disease Diagnostics Market Outlook, By Bacterial Infections (2022-2030) ($MN)
Table 106 South America Infectious Disease Diagnostics Market Outlook, By Viral Infections (2022-2030) ($MN)
Table 107 South America Infectious Disease Diagnostics Market Outlook, By Fungal Infections (2022-2030) ($MN)
Table 108 South America Infectious Disease Diagnostics Market Outlook, By Parasitic Infections (2022-2030) ($MN)
Table 109 South America Infectious Disease Diagnostics Market Outlook, By Other Infectious Diseases (2022-2030) ($MN)
Table 110 South America Infectious Disease Diagnostics Market Outlook, By Technology (2022-2030) ($MN)
Table 111 South America Infectious Disease Diagnostics Market Outlook, By Immunodiagnostics (2022-2030) ($MN)
Table 112 South America Infectious Disease Diagnostics Market Outlook, By Microbiology (2022-2030) ($MN)
Table 113 South America Infectious Disease Diagnostics Market Outlook, By Polymerase Chain Reaction (2022-2030) ($MN)
Table 114 South America Infectious Disease Diagnostics Market Outlook, By Next-generation Sequencing (2022-2030) ($MN)
Table 115 South America Infectious Disease Diagnostics Market Outlook, By Other Technologies (2022-2030) ($MN)
Table 116 South America Infectious Disease Diagnostics Market Outlook, By End User (2022-2030) ($MN)
Table 117 South America Infectious Disease Diagnostics Market Outlook, By Diagnostic Laboratories (2022-2030) ($MN)
Table 118 South America Infectious Disease Diagnostics Market Outlook, By Academic Research Institutes (2022-2030) ($MN)
Table 119 South America Infectious Disease Diagnostics Market Outlook, By Hospitals (2022-2030) ($MN)
Table 120 South America Infectious Disease Diagnostics Market Outlook, By Other End Users (2022-2030) ($MN)
Table 121 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Country (2022-2030) ($MN)
Table 122 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Product (2022-2030) ($MN)
Table 123 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Assays & Reagents (2022-2030) ($MN)
Table 124 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Kits (2022-2030) ($MN)
Table 125 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Consumables (2022-2030) ($MN)
Table 126 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Instruments (2022-2030) ($MN)
Table 127 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Software & Services (2022-2030) ($MN)
Table 128 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Disease (2022-2030) ($MN)
Table 129 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Bacterial Infections (2022-2030) ($MN)
Table 130 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Viral Infections (2022-2030) ($MN)
Table 131 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Fungal Infections (2022-2030) ($MN)
Table 132 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Parasitic Infections (2022-2030) ($MN)
Table 133 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Other Infectious Diseases (2022-2030) ($MN)
Table 134 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Technology (2022-2030) ($MN)
Table 135 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Immunodiagnostics (2022-2030) ($MN)
Table 136 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Microbiology (2022-2030) ($MN)
Table 137 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Polymerase Chain Reaction (2022-2030) ($MN)
Table 138 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Next-generation Sequencing (2022-2030) ($MN)
Table 139 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Other Technologies (2022-2030) ($MN)
Table 140 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By End User (2022-2030) ($MN)
Table 141 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Diagnostic Laboratories (2022-2030) ($MN)
Table 142 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Academic Research Institutes (2022-2030) ($MN)
Table 143 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Hospitals (2022-2030) ($MN)
Table 144 Middle East & Africa Infectious Disease Diagnostics Market Outlook, By Other End Users (2022-2030) ($MN)

Product Code: SMRC26354

According to Stratistics MRC, the Global Infectious Disease Diagnostics Market is accounted for $23.63 billion in 2024 and is expected to reach $42.78 billion by 2030 growing at a CAGR of 10.4% during the forecast period. Infectious disease diagnostics refers to the process of identifying the presence of pathogens, such as bacteria, viruses, fungi, or parasites, in a person's body to diagnose infectious diseases. These diagnostics involve various techniques and methods aimed at detecting specific pathogens or their markers, often through analyzing bodily fluids, tissues, or other samples. Rapid diagnostic tests (RDTs) are also utilized for quick identification in settings with limited resources. Accurate and timely diagnosis of infectious diseases is crucial for effective patient management, initiation of appropriate treatment, implementation of infection control measures, and disease surveillance.

According to the Centers for Disease Control and Prevention (CDC), in 2018, it was reported that approximately 1.7 million infections and 99,000 associated deaths occur every year in American hospitals. According to the U.S. Food and Drug Administration (FDA), in 2020, it was reported that around 300,000 individuals aged 50 and above are diagnosed with pneumococcal pneumonia, every year.

Market Dynamics:

Driver:

Growing demand for point-of-care testing

Point-of-care testing offers rapid, convenient, and decentralized testing solutions, allowing for quick diagnosis and timely treatment decisions at the patient's bedside or in community settings. This shift towards POCT is driven by several factors, including the need for faster turnaround times, especially in infectious disease outbreaks or pandemics like COVID-19. Additionally, POCT reduces the burden on centralized laboratory facilities and healthcare infrastructure, making testing more accessible to underserved populations and remote areas.

Restraint:

High cost of diagnostic tests

The high cost of diagnostic tests poses a significant barrier to the growth of the Infectious Disease Diagnostics Market. These costs encompass various aspects such as test development, manufacturing, and distribution, all of which contribute to the final price borne by patients and healthcare systems. For many individuals, especially in low- and middle-income countries, these expenses are prohibitive, leading to delayed or missed diagnoses and subsequent treatment. However, high costs can strain healthcare budgets, limiting access to essential diagnostic services.

Opportunity:

Rise in public health awareness

The rise in public health awareness has substantially contributed to the growth of the Infectious Disease Diagnostics Market. With an increasing understanding of the importance of early detection and prevention of infectious diseases, individuals and governments alike are investing more resources into diagnostic technologies. The global health crises, such as the COVID-19 pandemic, have highlighted the critical role of diagnostic testing in containing outbreaks and guiding public health responses. Consequently, there is a growing emphasis on the development and adoption of rapid, accurate, and cost-effective diagnostic solutions, driving innovation in the infectious disease diagnostics market and fostering collaborations between healthcare providers, research institutions and diagnostic companies.

Threat:

Complexity of diagnostic procedures

The complexity of diagnostic procedures poses a significant obstacle in the growth of the Infectious Disease Diagnostics Market. These complexities encompass various facets, including the technical intricacies involved in testing methodologies, lengthy turnaround times for obtaining results, and the requirement for skilled personnel to perform and interpret tests accurately. However, the diversity of infectious agents and their evolving nature further complicates diagnostic protocols, necessitating continuous updates and adaptations to detection techniques. These complexities not only increase the cost burden on healthcare systems but also impede timely and effective diagnosis and treatment of infectious diseases.

Covid-19 Impact:

The Covid-19 pandemic significantly impacted the infectious disease diagnostics market. There was an unprecedented surge in demand for diagnostic tests to detect the virus, leading to a rapid expansion of the market. The pandemic highlighted the importance of diagnostic testing in controlling infectious diseases, leading to increased investment in research and development for novel diagnostic technologies. However, the pandemic also disrupted supply chains and distribution networks, causing temporary shortages of testing kits and reagents.

The Fungal Infections segment is expected to be the largest during the forecast period

The fungal infections segment is anticipated to be the largest in the infectious disease diagnostics market during the forecast period due to the rising prevalence of invasive fungal diseases, particularly among immunocompromised individuals. Increased awareness, advancements in diagnostic technologies, and the need for timely and accurate identification of fungal pathogens drive market growth. The growing incidence of hospital-acquired infections and the high morbidity and mortality rates associated with fungal infections further contribute to the segment's expansion.

The Next-generation Sequencing segment is expected to have the highest CAGR during the forecast period

Next-generation Sequencing segment is expected to have the highest CAGR during the forecast period by enabling rapid and comprehensive analysis of pathogens' genetic material. This technology allows for the simultaneous detection and characterization of multiple infectious agents, including bacteria, viruses, fungi, and parasites, in a single test. By sequencing the entire genome or specific regions of pathogens, NGS can provide valuable insights into their genetic diversity, drug resistance profiles, and epidemiological patterns. This comprehensive approach enhances the accuracy and efficiency of infectious disease diagnosis, particularly in cases where traditional methods may fail to identify the causative agent or distinguish between closely related strains. Additionally, NGS facilitates the detection of emerging infectious diseases and the monitoring of outbreaks in real-time, empowering healthcare professionals to implement timely and targeted interventions for better disease management and control.

Region with largest share:

Asia Pacific region commanded the largest share of the market throughout the extrapolated period. As populations age, there's a natural increase in susceptibility to infectious diseases due to weakened immune systems and other age-related factors. This demographic shift creates a higher demand for diagnostic tools and services to effectively detect and manage infectious diseases among the elderly. Additionally, factors such as urbanization, changing lifestyles, and increased access to healthcare facilities further contribute to the expansion of the infectious disease diagnostics market in the region.

Region with highest CAGR:

Europe region is poised to hold profitable growth during the projection period. Through stringent regulatory frameworks, such as the European Union's In Vitro Diagnostic Regulation (IVDR), authorities ensure the quality, safety, and efficacy of diagnostic tests. These regulations not only set high standards for product development and manufacturing but also facilitate timely approvals and market access for innovative diagnostic technologies. Moreover, compliance with these regulations fosters trust among healthcare professionals and patients, thereby driving the regional adoption of advanced diagnostic solutions.

Key players in the market

Some of the key players in Infectious Disease Diagnostics market include Bio-Rad Laboratories, Inc, Hologic, Inc, Luminex Corporation, Abbott Laboratories, GenMark Diagnostics, Inc, PerkinElmer, Inc, Thermo Fisher Scientific Inc, Bruker Corporation, Sysmex Corporation, Nanosphere Health Sciences Inc, Trinity Biotech plc, InBios International, Inc and Meridian Bioscience, Inc.

Key Developments:

In February 2023, Abbott to acquire Cardiovascular Systems for $837.6 mln. The deal will help Abbott gain access to CSI's minimally invasive device to treat blocked arteries.

In May 2022, Quidel Corporation a US-based company that provides rapid diagnostic testing solutions, cellular-based virology assays, and molecular diagnostic systems, has acquired Ortho Clinical Diagnostics and the succeeding business groups.

Products Covered:

Assays & Reagents
Kits
Consumables
Instruments
Software & Services

Diseases Covered:

Bacterial Infections
Viral Infections
Fungal Infections
Parasitic Infections
Other Diseases

Technologies Covered:

Immunodiagnostics
Microbiology
Polymerase Chain Reaction
Next-generation Sequencing
Other Technologies

End Users Covered:

Diagnostic Laboratories
Academic Research Institutes
Hospitals
Other End Users

Regions Covered:

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
South America
- Argentina
- Brazil
- Chile
- Rest of South America
Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

2 Preface

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Infectious Disease Diagnostics Market, By Product

5.1 Introduction
5.2 Assays & Reagents
5.3 Kits
5.4 Consumables
5.5 Instruments
5.6 Software & Services

6 Global Infectious Disease Diagnostics Market, By Disease

6.1 Introduction
6.2 Bacterial Infections
6.3 Viral Infections
6.4 Fungal Infections
6.5 Parasitic Infections
6.6 Other Infectious Diseases

7 Global Infectious Disease Diagnostics Market, By Technology

7.1 Introduction
7.2 Immunodiagnostics
7.3 Microbiology
7.4 Polymerase Chain Reaction
7.5 Next-generation Sequencing
7.6 Other Technologies

8 Global Infectious Disease Diagnostics Market, By End User

8.1 Introduction
8.2 Diagnostic Laboratories
8.3 Academic Research Institutes
8.4 Hospitals
8.5 Other End Users

9 Global Infectious Disease Diagnostics Market, By Geography

9.1 Introduction
9.2 North America
- 9.2.1 US
- 9.2.2 Canada
- 9.2.3 Mexico
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 Italy
- 9.3.4 France
- 9.3.5 Spain
- 9.3.6 Rest of Europe
9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 New Zealand
- 9.4.6 South Korea
- 9.4.7 Rest of Asia Pacific
9.5 South America
- 9.5.1 Argentina
- 9.5.2 Brazil
- 9.5.3 Chile
- 9.5.4 Rest of South America
9.6 Middle East & Africa
- 9.6.1 Saudi Arabia
- 9.6.2 UAE
- 9.6.3 Qatar
- 9.6.4 South Africa
- 9.6.5 Rest of Middle East & Africa

10 Key Developments

10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 Company Profiling

11.1 Bio-Rad Laboratories, Inc
11.2 Hologic, Inc
11.3 Luminex Corporation
11.4 Abbott Laboratories
11.5 GenMark Diagnostics, Inc
11.6 PerkinElmer, Inc
11.7 Thermo Fisher Scientific Inc
11.8 Bruker Corporation
11.9 Sysmex Corporation
11.10 Nanosphere Health Sciences Inc
11.11 Trinity Biotech plc
11.12 InBios International, Inc
11.13 Meridian Bioscience, Inc

感染症診断の世界市場：分析 - 製品別、疾患別、技術別、エンドユーザー別、地域別、予測（～2030年）

Infectious Disease Diagnostics Market Forecasts to 2030 - Global Analysis By Product, Disease, Technology, End User and By Geography

COVID-19の影響：

最大のシェアを占める地域

CAGRが最も高い地域：

目次

第1章 エグゼクティブサマリー

第2章 序文

第3章 市場動向分析

第4章 ポーターのファイブフォース分析

第5章 世界の感染症診断市場：製品別

第6章 世界の感染症診断市場：疾患別

第7章 世界の感染症診断市場：技術別

第8章 世界の感染症診断市場：エンドユーザー別

第9章 世界の感染症診断市場：地域別

第10章 主な発展

第11章 企業プロファイリング